{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:18:55Z","timestamp":1767842335599,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,17]],"date-time":"2008-01-17T00:00:00Z","timestamp":1200528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,17]],"date-time":"2008-01-17T00:00:00Z","timestamp":1200528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.jp.7211929","type":"journal-article","created":{"date-parts":[[2008,1,17]],"date-time":"2008-01-17T09:31:33Z","timestamp":1200562293000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Secretory phospholipase A2 in newborn infants with sepsis"],"prefix":"10.1038","volume":"28","author":[{"given":"A J J","family":"Schrama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"de Beaufort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B J H M","family":"Poorthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F J","family":"Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,17]]},"reference":[{"key":"BF7211929_CR1","first-page":"943","volume-title":"Infectious Diseases of the Fetus and Newborn Infant","author":"JO Klein","year":"2000","unstructured":"Klein JO . Bacterial sepsis and meningitis. In: Remington JS, Klein JO (eds). Infectious Diseases of the Fetus and Newborn Infant. Saunders: Philadelphia, 2000, pp 943\u2013998."},{"key":"BF7211929_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1203\/00006450-200203000-00009","volume":"51","author":"C Schultz","year":"2002","unstructured":"Schultz C, Rott C, Temming P, Schlenke P, Moller JC, Bucsky P . Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51: 317\u2013322.","journal-title":"Pediatr Res"},{"key":"BF7211929_CR3","first-page":"23","volume-title":"Infectious Diseases of the Fetus and Newborn Infant","author":"DBWC Lewis","year":"2000","unstructured":"Lewis DBWC . Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO (eds). Infectious Diseases of the Fetus and Newborn Infant. Saunders: Philadelphia, 2000, pp 23\u2013138."},{"key":"BF7211929_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0031-3955(05)70469-7","volume":"44","author":"MR Anderson","year":"1997","unstructured":"Anderson MR, Blumer JL . Advances in the therapy for sepsis in children. Pediatr Clin North Am 1997; 44: 179\u2013205.","journal-title":"Pediatr Clin North Am"},{"issue":"Suppl 1","key":"BF7211929_CR5","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1007\/s001340000574","volume":"27","author":"P Arndt","year":"2001","unstructured":"Arndt P, Abraham E . Immunological therapy of sepsis: experimental therapies. Intensive Care Med 2001; 27 (Suppl 1): S104\u2013S115.","journal-title":"Intensive Care Med"},{"key":"BF7211929_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0024-3205(92)90186-S","volume":"50","author":"P Vadas","year":"1992","unstructured":"Vadas P, Scott K, Smith G, Rajkovic I, Stefanski E, Schouten BD et al. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci 1992; 50: 807\u2013811.","journal-title":"Life Sci"},{"key":"BF7211929_CR7","first-page":"413","volume":"90","author":"S Endo","year":"1995","unstructured":"Endo S, Inada K, Nakae H, Takakuwa T, Yamada Y, Suzuki T et al. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis. Res Commun Mol Pathol Pharmacol 1995; 90: 413\u2013421.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"BF7211929_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbalip.2004.12.012","volume":"1733","author":"TJ Nevalainen","year":"2005","unstructured":"Nevalainen TJ, Eerola LI, Rintala E, Laine VJ, Lambeau G, Gelb MH . Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta 2005; 1733: 210\u2013223.","journal-title":"Biochim Biophys Acta"},{"key":"BF7211929_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbalip.2006.08.003","volume":"1761","author":"S Yedgar","year":"2006","unstructured":"Yedgar S, Cohen Y, Shoseyov D . Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta 2006; 1761: 1373\u20131382.","journal-title":"Biochim Biophys Acta"},{"key":"BF7211929_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1357-4310(99)01470-7","volume":"5","author":"L Touqui","year":"1999","unstructured":"Touqui L, Arbibe L . A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999; 5: 244\u2013249.","journal-title":"Mol Med Today"},{"key":"BF7211929_CR11","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1074\/jbc.M109777200","volume":"277","author":"SA Beers","year":"2002","unstructured":"Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC . The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem 2002; 277: 1788\u20131793.","journal-title":"J Biol Chem"},{"key":"BF7211929_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/003655101753218283","volume":"61","author":"EM Rintala","year":"2001","unstructured":"Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J . Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest 2001; 61: 523\u2013530.","journal-title":"Scand J Clin Lab Invest"},{"key":"BF7211929_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000047118","volume":"80","author":"H Dollner","year":"2001","unstructured":"Dollner H, Vatten L, Linnebo I, Zanussi GF, Laerdal A, Austgulen R . Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate 2001; 80: 41\u201347.","journal-title":"Biol Neonate"},{"key":"BF7211929_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1651-2227.2001.tb00442.x","volume":"90","author":"AJ Schrama","year":"2001","unstructured":"Schrama AJ, de Beaufort AJ, Sukul YR, Jansen SM, Poorthuis BJ, Berger HM . Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study. Acta Paediatr 2001; 90: 412\u2013416.","journal-title":"Acta Paediatr"},{"key":"BF7211929_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/000456328502200309","volume":"22","author":"I Byrjalsen","year":"1985","unstructured":"Byrjalsen I, Ingwersen SH . Immunoturbidimetry of serum C-reactive protein in low concentration of polyethylene glycol. Ann Clin Biochem 1985; 22: 269\u2013272.","journal-title":"Ann Clin Biochem"},{"key":"BF7211929_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00006454-200009000-00014","volume":"19","author":"S Mehr","year":"2000","unstructured":"Mehr S, Doyle LW . Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 2000; 19: 879\u2013887.","journal-title":"Pediatr Infect Dis J"},{"key":"BF7211929_CR17","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0021-9258(18)52293-6","volume":"266","author":"RM Crowl","year":"1991","unstructured":"Crowl RM, Stoller TJ, Conroy RR, Stoner CR . Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647\u20132651.","journal-title":"J Biol Chem"},{"key":"BF7211929_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-2952(01)00841-3","volume":"63","author":"A Gambero","year":"2002","unstructured":"Gambero A, Landucci EC, Toyama MH, Marangoni S, Giglio JR, Nader HB et al. Human neutrophil migration in vitro induced by secretory phospholipases A2: a role for cell surface glycosaminoglycans. Biochem Pharmacol 2002; 63: 65\u201372.","journal-title":"Biochem Pharmacol"},{"key":"BF7211929_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00917507","volume":"15","author":"W Pruzanski","year":"1991","unstructured":"Pruzanski W, Saito S, Stefanski E, Vadas P . Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes. Inflammation 1991; 15: 127\u2013135.","journal-title":"Inflammation"},{"key":"BF7211929_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","volume":"20","author":"G Lambeau","year":"1999","unstructured":"Lambeau G, Lazdunski M . Receptors for a growing family of secreted phospholipases A2 . Trends Pharmacol Sci 1999; 20: 162\u2013170.","journal-title":"Trends Pharmacol Sci"},{"key":"BF7211929_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0014-5793(98)01490-2","volume":"440","author":"J Takasaki","year":"1998","unstructured":"Takasaki J, Kawauchi Y, Urasaki T, Tanaka H, Usuda S, Masuho Y . Antibodies against type II phospholipase A2 prevent renal injury due to ischemia and reperfusion in rats. FEBS Lett 1998; 440: 377\u2013381.","journal-title":"FEBS Lett"},{"key":"BF7211929_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00003246-200104000-00004","volume":"29","author":"S Furue","year":"2001","unstructured":"Furue S, Mikawa K, Nishina K, Shiga M, Ueno M, Tomita Y et al. Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection. Crit Care Med 2001; 29: 719\u2013727.","journal-title":"Crit Care Med"},{"key":"BF7211929_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0167-5699(97)01002-5","volume":"18","author":"CE Hack","year":"1997","unstructured":"Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den BH . A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 1997; 18: 111\u2013115.","journal-title":"Immunol Today"},{"key":"BF7211929_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1515\/JPM.2005.076","volume":"33","author":"R Mittendorf","year":"2005","unstructured":"Mittendorf R, Covert R, Montag AG, elMasri W, Muraskas J, Lee KS et al. Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates. J Perinat Med 2005; 33: 428\u2013434.","journal-title":"J Perinat Med"},{"key":"BF7211929_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/BF01991918","volume":"154","author":"C Berger","year":"1995","unstructured":"Berger C, Uehlinger J, Ghelfi D, Blau N, Fanconi S . Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia. Eur J Pediatr 1995; 154: 138\u2013144.","journal-title":"Eur J Pediatr"},{"key":"BF7211929_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1203\/01.pdr.0000200808.35368.57","volume":"59","author":"MA Verboon-Maciolek","year":"2006","unstructured":"Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet TG et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006; 59: 457\u2013461.","journal-title":"Pediatr Res"},{"key":"BF7211929_CR27","first-page":"39","volume":"27","author":"E Rintala","year":"1995","unstructured":"Rintala E, Pulkki K, Mertsola J, Nevalainen T, Nikoskelainen J . Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies. Scand J Infect Dis 1995; 27: 39\u201343.","journal-title":"Scand J Infect Dis"},{"key":"BF7211929_CR28","first-page":"1254","volume":"274","author":"LA Marshall","year":"1995","unstructured":"Marshall LA, Hall RH, Winkler JD, Badger A, Bolognese B, Roshak A et al. SB 203347, an inhibitor of 14\u2009kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. J Pharmacol Exp Ther 1995; 274: 1254\u20131262.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF7211929_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0020-1383(98)00178-8","volume":"30","author":"SM Song","year":"1999","unstructured":"Song SM, Lu SM, Wang ZG, Liu JC, Guo SQ, Li Z . Subcellular membrane impairment and application of phospholipase A2 inhibitors in endotoxic shock. Injury 1999; 30: 9\u201314.","journal-title":"Injury"},{"key":"BF7211929_CR30","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1097\/01.CCM.0000171540.54520.69","volume":"33","author":"BG Zeiher","year":"2005","unstructured":"Zeiher BG, Steingrub J, Laterre PF, Dmitrienko A, Fukiishi Y, Abraham E . LY315920NA\/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med 2005; 33: 1741\u20131748.","journal-title":"Crit Care Med"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7211929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211929","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:52:50Z","timestamp":1647607970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7211929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,17]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF7211929"],"URL":"https:\/\/doi.org\/10.1038\/sj.jp.7211929","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,17]]},"assertion":[{"value":"2 October 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}